0001127602-23-014583.txt : 20230504
0001127602-23-014583.hdr.sgml : 20230504
20230504183704
ACCESSION NUMBER: 0001127602-23-014583
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LeCointe-Cephas Lisa
CENTRAL INDEX KEY: 0001854644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 23890584
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL RD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-02
0000310158
Merck & Co., Inc.
MRK
0001854644
LeCointe-Cephas Lisa
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
SVP Chief Ethics & Com Officer
0
Common Stock
4154.693
D
Stock Option (Right to Buy)
117.89
2023-05-02
4
A
0
9682
0
A
2024-05-02
2033-05-01
Common Stock
9682
9682
D
Restricted Stock Unit
2023-05-02
4
A
0
1781
0
A
2024-05-02
2026-05-02
Common Stock
1781
1781
D
The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
/s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
2023-05-04